also from thinkBiotech:

Building Biotechnology: Starting, Managing, and Understanding Biotechnology Companies

DrugPatentWatch.com - Premium Plan
DrugPatentWatch - Online Approved Drug Database


You are viewing the June 2000 archive
Go to the current data set


Instant Access with secure payment processing:

 Drug patentsDrug patent expirationsPatent expirationDrug sales
$235 / One Month $975 / One Year
One Month One Year
Need an invoice? Group rate? Contact admin@DrugPatentWatch.com

Listing of Drug Product Information by Applicant - K

Range: 1 - 5

ApplicantTradenameGeneric NameNDAApproval DateTypePatent NumberPatent ExpirationExclusivity Expiration
KalapharmFUROSEMIDEfurosemide018868Jun 28, 1983RX
KalapharmGENTAMICIN SULFATEgentamicin sulfate062354Apr 05, 1982RX
Kendall IlCHLORHEXIDINE GLUCONATEchlorhexidine gluconate019490Mar 27, 1987OTC
Kendall IlLARYNGOTRACHEAL ANESTHESIA KITlidocaine hydrochloride087931Jun 10, 1983DISCN
Kendall LpTHERMAZENEsilver sulfadiazine018810Dec 23, 1985RX

 Complete access available with subscription 

   A   B   C   D   E   F   G   H   I   J   K   L   M   N   O   P   Q   R   S   T   U   V   W   X   Y   Z   
All listed trade names are property of their owners or licensors.
Raw information from FDA Orange Book, USPTO and other sources. Copyright © 2009 thinkBiotech LLC

Back to main search page


[ Home | Free Patent Expiration Bulletin | Pharmaceutical Innovation Dashboard | Media Access | Affiliate Program | Contact ]

Bookmark This Site

Drug Patent Expiration Dates

DISCLAIMER:
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek independent professional advice before acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

All trademarks and applicant names are the property of their respective owners or licensors.